ArticleAmerican journal of public health2020
Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada.
Abstract read
In one paragraph
Article in American journal of public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
48 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials.Addiction (Abingdon, England) · 2023Pooled it
- Pooled it
- Recent hydromorphone injection and risk of incident infective endocarditis among people who inject drugs in Toronto, Canada: a cohort study.Harm reduction journal · 2026Article
- Incidence of HIV and HCV Among People Who Inject Drugs in Montreal, Canada: Data From the HEPCO Longitudinal Cohort Study, 2011-2025.Journal of viral hepatitis · 2026Article
- Retention in opioid agonist treatment during pregnancy and variations according to treatment and maternal characteristics.Addiction (Abingdon, England) · 2026Article
- Article
- Economic and epidemiological burden of medical complications of unregulated drug use among people who inject drugs in Québec.Substance abuse treatment, prevention, and policy · 2026Article
- Article
- Commentary on Jiang et al.Canadian liver journal · 2025Article
- "From an HCV and HIV point of view, it's been remarkable": A qualitative study about using prescribed safer supply to support people who use drugs along the HIV and HCV prevention and treatment cascades in Ontario, Canada.Journal of the International AIDS Society · 2025Article
- Estimating the population size of people who inject drugs in Canada, 2021.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2025Review
- The Impact of COVID-19 and Related Public Health Measures on Hepatitis C Testing in Ontario, Canada.Viruses · 2025Article
- Exploring housing instability through a gender lens among people who inject drugs in Montreal, Canada.Drug and alcohol review · 2025Article
- Improving implementation of needle and syringe programmes to expand, scale up, and sustain evidence-based prevention interventions for HIV and hepatitis C in prisons.The Lancet. Public health · 2025Article
- Infective Endocarditis Among Women Who Inject Drugs.JAMA network open · 2024Article
- Overdose prevention centres as spaces of safety, trust and inclusion: A causal pathway based on a realist review.Drug and alcohol review · 2024Review
- What features of drug treatment programs help, or not, with access? a qualitative study of the perspectives of family members and community-based organization staff in Atlantic Canada.Substance abuse treatment, prevention, and policy · 2024Article
- Article
- Article
- Successes and challenges of best practice alerts to identify and engage individuals living with hepatitis C virus.Frontiers in public health · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Brendan JackaBrendan Jacka, Stine Hoj, and Julie Bruneau are with Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal, Quebec. Canada. Sarah Larney and Louisa Degenhardt are with National Drug and Alcohol Research Centre, UNSW Sydney, NSW, Australia. Naveed Janjua and Mel Krajden are with British Columbia Centres for Disease Control, Vancouver, British Columbia, Canada. Jason Grebely is with The Kirby Institute, UNSW Sydney.
Sarah LarneyBrendan Jacka, Stine Hoj, and Julie Bruneau are with Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal, Quebec. Canada. Sarah Larney and Louisa Degenhardt are with National Drug and Alcohol Research Centre, UNSW Sydney, NSW, Australia. Naveed Janjua and Mel Krajden are with British Columbia Centres for Disease Control, Vancouver, British Columbia, Canada. Jason Grebely is with The Kirby Institute, UNSW Sydney.
Louisa DegenhardtBrendan Jacka, Stine Hoj, and Julie Bruneau are with Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal, Quebec. Canada. Sarah Larney and Louisa Degenhardt are with National Drug and Alcohol Research Centre, UNSW Sydney, NSW, Australia. Naveed Janjua and Mel Krajden are with British Columbia Centres for Disease Control, Vancouver, British Columbia, Canada. Jason Grebely is with The Kirby Institute, UNSW Sydney.
Naveed JanjuaBrendan Jacka, Stine Hoj, and Julie Bruneau are with Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal, Quebec. Canada. Sarah Larney and Louisa Degenhardt are with National Drug and Alcohol Research Centre, UNSW Sydney, NSW, Australia. Naveed Janjua and Mel Krajden are with British Columbia Centres for Disease Control, Vancouver, British Columbia, Canada. Jason Grebely is with The Kirby Institute, UNSW Sydney.
Stine HøjBrendan Jacka, Stine Hoj, and Julie Bruneau are with Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal, Quebec. Canada. Sarah Larney and Louisa Degenhardt are with National Drug and Alcohol Research Centre, UNSW Sydney, NSW, Australia. Naveed Janjua and Mel Krajden are with British Columbia Centres for Disease Control, Vancouver, British Columbia, Canada. Jason Grebely is with The Kirby Institute, UNSW Sydney.
Mel KrajdenBrendan Jacka, Stine Hoj, and Julie Bruneau are with Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal, Quebec. Canada. Sarah Larney and Louisa Degenhardt are with National Drug and Alcohol Research Centre, UNSW Sydney, NSW, Australia. Naveed Janjua and Mel Krajden are with British Columbia Centres for Disease Control, Vancouver, British Columbia, Canada. Jason Grebely is with The Kirby Institute, UNSW Sydney.
Jason GrebelyBrendan Jacka, Stine Hoj, and Julie Bruneau are with Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal, Quebec. Canada. Sarah Larney and Louisa Degenhardt are with National Drug and Alcohol Research Centre, UNSW Sydney, NSW, Australia. Naveed Janjua and Mel Krajden are with British Columbia Centres for Disease Control, Vancouver, British Columbia, Canada. Jason Grebely is with The Kirby Institute, UNSW Sydney.
Julie BruneauBrendan Jacka, Stine Hoj, and Julie Bruneau are with Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal, Quebec. Canada. Sarah Larney and Louisa Degenhardt are with National Drug and Alcohol Research Centre, UNSW Sydney, NSW, Australia. Naveed Janjua and Mel Krajden are with British Columbia Centres for Disease Control, Vancouver, British Columbia, Canada. Jason Grebely is with The Kirby Institute, UNSW Sydney.
Funding
Using existing data to understand and ameliorate risk in opioid agonist therapyR01DA044170 · NIDA · UNIVERSITY OF NEW SOUTH WALES · PI DEGENHARDT, LOUISA · 2017 to 2019
$641kNIDA NIH HHS R01 DA044170
Abstract
PubMed holds no abstract for this paper.
Indexed as
Analgesics, OpioidCanadaFemaleHarm ReductionHepatitis CHIV InfectionsHumansLongitudinal StudiesMaleNeedle-Exchange ProgramsOpiate Substitution TreatmentOpioid-Related DisordersPrevalenceSubstance Abuse, IntravenousAnalgesics, Opioid
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.